Sign in
Effect of single annual infusion of zoledronic acid on bone turnover markers versus daily oral risedronate in patients with glucocorticoid-induced osteoporosis
Conference proceeding   Peer reviewed

Effect of single annual infusion of zoledronic acid on bone turnover markers versus daily oral risedronate in patients with glucocorticoid-induced osteoporosis

P. Sambrook, D. Reid, Jean-Pierre Devogelaer, Jean-Yves Reginster, K. Saag, Christian Roux, P. Papanastasiou, K. Maylandt, T. Fashola and P. Mesenbrink
Osteoporosis International, 20 (Suppl.1), S128-129 (2009-04); Ninth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Athens, Greece [GR], du 18 mars 2009 au 21 mars 2009
04/2009

Abstract

General & internal medicine Human health sciences Médecine générale & interne Public health, health care sciences & services Santé publique, services médicaux & soins de santé Sciences de la santé humaine

Metrics

1 Record Views

Details